China Glial Cell Line Derived Neurotrophic Factor Market Research Report 2018

March 2018 | 95 pages | ID: C01AC386E14EN
QYResearch

Abstracts

The global Glial Cell Line Derived Neurotrophic Factor market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Glial Cell Line Derived Neurotrophic Factor development status and future trend in China, focuses on top players in China, also splits Glial Cell Line Derived Neurotrophic Factor by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• GlaxoSmithKline Plc
• Treeway BV
• UniQure NV

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• GSK-812
• LAUR-301
• TW-002
• AMT-090
• Others

On the basis of the end users/application, this report covers

• Amyotrophic Lateral Sclerosis
• Brain Ischemia
• Parkinson's Disease
• Retinal Degeneration
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Glial Cell Line Derived Neurotrophic Factor Market Research Report 2018

1 GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR OVERVIEW

1.1 Product Overview and Scope of Glial Cell Line Derived Neurotrophic Factor
1.2 Classification of Glial Cell Line Derived Neurotrophic Factor by Product Category
  1.2.1 China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) Comparison by Type (2013-2025)
  1.2.2 China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) Market Share by Type in 2017
  1.2.3 GSK-812
  1.2.4 LAUR-301
  1.2.5 TW-002
  1.2.6 AMT-090
  1.2.7 Others
1.3 China Glial Cell Line Derived Neurotrophic Factor Market by Application/End Users
  1.3.1 China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Amyotrophic Lateral Sclerosis
  1.3.3 Brain Ischemia
  1.3.4 Parkinson's Disease
  1.3.5 Retinal Degeneration
  1.3.6 Others
1.4 China Glial Cell Line Derived Neurotrophic Factor Market by Region
  1.4.1 China Glial Cell Line Derived Neurotrophic Factor Market Size (Million USD) Comparison by Region (2013-2025)
  1.4.2 South China Glial Cell Line Derived Neurotrophic Factor Status and Prospect (2013-2025)
  1.4.3 East China Glial Cell Line Derived Neurotrophic Factor Status and Prospect (2013-2025)
  1.4.4 Southwest China Glial Cell Line Derived Neurotrophic Factor Status and Prospect (2013-2025)
  1.4.5 Northeast China Glial Cell Line Derived Neurotrophic Factor Status and Prospect (2013-2025)
  1.4.6 North China Glial Cell Line Derived Neurotrophic Factor Status and Prospect (2013-2025)
  1.4.7 Central China Glial Cell Line Derived Neurotrophic Factor Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Glial Cell Line Derived Neurotrophic Factor (2013-2025)
  1.5.1 China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) and Growth Rate (%)(2013-2025)
  1.5.2 China Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 CHINA GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Glial Cell Line Derived Neurotrophic Factor Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Glial Cell Line Derived Neurotrophic Factor Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Glial Cell Line Derived Neurotrophic Factor Average Price (USD/Pcs) by Players/Manufacturers (2013-2018)
2.4 China Glial Cell Line Derived Neurotrophic Factor Market Competitive Situation and Trends
  2.4.1 China Glial Cell Line Derived Neurotrophic Factor Market Concentration Rate
  2.4.2 China Glial Cell Line Derived Neurotrophic Factor Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Glial Cell Line Derived Neurotrophic Factor Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR SALES AND REVENUE BY REGION (2013-2018)

3.1 China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) and Market Share by Region (2013-2018)
3.2 China Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Glial Cell Line Derived Neurotrophic Factor Price (USD/Pcs) by Regions (2013-2018)

4 CHINA GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2013-2018)

4.1 China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018)
4.2 China Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Glial Cell Line Derived Neurotrophic Factor Price (USD/Pcs) by Type (2013-2018)
4.4 China Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (%) by Type (2013-2018)

5 CHINA GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR SALES BY APPLICATION (2013-2018)

5.1 China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) and Market Share by Application (2013-2018)
5.2 China Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 CHINA GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GlaxoSmithKline Plc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Glial Cell Line Derived Neurotrophic Factor Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Treeway BV
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Glial Cell Line Derived Neurotrophic Factor Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Treeway BV Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.2.4 Main Business/Business Overview
6.3 UniQure NV
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Glial Cell Line Derived Neurotrophic Factor Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 UniQure NV Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.3.4 Main Business/Business Overview

7 GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR MANUFACTURING COST ANALYSIS

7.1 Glial Cell Line Derived Neurotrophic Factor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Glial Cell Line Derived Neurotrophic Factor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Glial Cell Line Derived Neurotrophic Factor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Glial Cell Line Derived Neurotrophic Factor Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

11.1 China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025)
11.2 China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) Forecast by Type (2018-2025)
11.3 China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) Forecast by Application (2018-2025)
11.4 China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) by Application (2013-2025)
Figure Product Picture of Glial Cell Line Derived Neurotrophic Factor
Table China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Glial Cell Line Derived Neurotrophic Factor Sales Volume Market Share by Types in 2017
Figure GSK-812 Product Picture
Figure LAUR-301 Product Picture
Figure TW-002 Product Picture
Figure AMT-090 Product Picture
Figure Others Product Picture
Figure China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Glial Cell Line Derived Neurotrophic Factor by Application in 2017
Figure Amyotrophic Lateral Sclerosis Examples
Table Key Downstream Customer in Amyotrophic Lateral Sclerosis
Figure Brain Ischemia Examples
Table Key Downstream Customer in Brain Ischemia
Figure Parkinson's Disease Examples
Table Key Downstream Customer in Parkinson's Disease
Figure Retinal Degeneration Examples
Table Key Downstream Customer in Retinal Degeneration
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) and Growth Rate (%)(2013-2025)
Figure China Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Glial Cell Line Derived Neurotrophic Factor Sales of Key Players/Manufacturers (2013-2018)
Table China Glial Cell Line Derived Neurotrophic Factor Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Glial Cell Line Derived Neurotrophic Factor Sales Share (%) by Players/Manufacturers
Figure 2017 China Glial Cell Line Derived Neurotrophic Factor Sales Share (%) by Players/Manufacturers
Table China Glial Cell Line Derived Neurotrophic Factor Revenue by Players/Manufacturers (2013-2018)
Table China Glial Cell Line Derived Neurotrophic Factor Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Glial Cell Line Derived Neurotrophic Factor Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Glial Cell Line Derived Neurotrophic Factor Revenue Market Share (%) by Players/Manufacturers
Table China Market Glial Cell Line Derived Neurotrophic Factor Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Glial Cell Line Derived Neurotrophic Factor Average Price of Key Players/Manufacturers in 2017
Figure China Glial Cell Line Derived Neurotrophic Factor Market Share of Top 3 Players/Manufacturers
Figure China Glial Cell Line Derived Neurotrophic Factor Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Glial Cell Line Derived Neurotrophic Factor Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Glial Cell Line Derived Neurotrophic Factor Product Category
Table China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) by Regions (2013-2018)
Table China Glial Cell Line Derived Neurotrophic Factor Sales Share (%) by Regions (2013-2018)
Figure China Glial Cell Line Derived Neurotrophic Factor Sales Share (%) by Regions (2013-2018)
Figure China Glial Cell Line Derived Neurotrophic Factor Sales Market Share (%) by Regions in 2017
Table China Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Glial Cell Line Derived Neurotrophic Factor Revenue Market Share (%) by Regions (2013-2018)
Figure China Glial Cell Line Derived Neurotrophic Factor Revenue Market Share (%) by Regions (2013-2018)
Figure China Glial Cell Line Derived Neurotrophic Factor Revenue Market Share (%) by Regions in 2017
Table China Glial Cell Line Derived Neurotrophic Factor Price (USD/Pcs) by Regions (2013-2018)
Table China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) by Type (2013-2018)
Table China Glial Cell Line Derived Neurotrophic Factor Sales Share (%) by Type (2013-2018)
Figure China Glial Cell Line Derived Neurotrophic Factor Sales Share (%) by Type (2013-2018)
Figure China Glial Cell Line Derived Neurotrophic Factor Sales Market Share (%) by Type in 2017
Table China Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Glial Cell Line Derived Neurotrophic Factor Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Glial Cell Line Derived Neurotrophic Factor by Type (2013-2018)
Figure Revenue Market Share of Glial Cell Line Derived Neurotrophic Factor by Type in 2017
Table China Glial Cell Line Derived Neurotrophic Factor Price (USD/Pcs) by Types (2013-2018)
Figure China Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (%) by Type (2013-2018)
Table China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) by Applications (2013-2018)
Table China Glial Cell Line Derived Neurotrophic Factor Sales Market Share (%) by Applications (2013-2018)
Figure China Glial Cell Line Derived Neurotrophic Factor Sales Market Share (%) by Application (2013-2018)
Figure China Glial Cell Line Derived Neurotrophic Factor Sales Market Share (%) by Application in 2017
Table China Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (%) by Application (2013-2018)
Figure China Glial Cell Line Derived Neurotrophic Factor Sales Growth Rate (%) by Application (2013-2018)
Table GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Basic Information List
Table GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Sales Market Share (%) in China (2013-2018)
Figure GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Revenue Market Share (%) in China (2013-2018)
Table Treeway BV Glial Cell Line Derived Neurotrophic Factor Basic Information List
Table Treeway BV Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Treeway BV Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Treeway BV Glial Cell Line Derived Neurotrophic Factor Sales Market Share (%) in China (2013-2018)
Figure Treeway BV Glial Cell Line Derived Neurotrophic Factor Revenue Market Share (%) in China (2013-2018)
Table UniQure NV Glial Cell Line Derived Neurotrophic Factor Basic Information List
Table UniQure NV Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure UniQure NV Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure UniQure NV Glial Cell Line Derived Neurotrophic Factor Sales Market Share (%) in China (2013-2018)
Figure UniQure NV Glial Cell Line Derived Neurotrophic Factor Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glial Cell Line Derived Neurotrophic Factor
Figure Manufacturing Process Analysis of Glial Cell Line Derived Neurotrophic Factor
Figure Glial Cell Line Derived Neurotrophic Factor Industrial Chain Analysis
Table Raw Materials Sources of Glial Cell Line Derived Neurotrophic Factor Major Players/Manufacturers in 2017
Table Major Buyers of Glial Cell Line Derived Neurotrophic Factor
Table Distributors/Traders List
Figure China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure China Glial Cell Line Derived Neurotrophic Factor Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Glial Cell Line Derived Neurotrophic Factor Price (USD/Pcs) Trend Forecast (2018-2025)
Table China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) Forecast by Type (2018-2025)
Figure China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) Forecast by Type (2018-2025)
Figure China Glial Cell Line Derived Neurotrophic Factor Sales Volume Market Share Forecast by Type in 2025
Table China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) Forecast by Application (2018-2025)
Figure China Glial Cell Line Derived Neurotrophic Factor Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Glial Cell Line Derived Neurotrophic Factor Sales Volume Market Share Forecast by Application in 2025
Table China Glial Cell Line Derived Neurotrophic Factor Sales (K Pcs) Forecast by Regions (2018-2025)
Table China Glial Cell Line Derived Neurotrophic Factor Sales Volume Share Forecast by Regions (2018-2025)
Figure China Glial Cell Line Derived Neurotrophic Factor Sales Volume Share Forecast by Regions (2018-2025)
Figure China Glial Cell Line Derived Neurotrophic Factor Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources